Sofia, Bulgaria, June 7, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for May 2021 the Company recorded a increase in sales of 15% compared to the same month of the previous year, incl. 89% increase in domestic sales and 27% decrease in export sales.
In the first five months of 2021 the revenues from sales of products decrease by 20% compared to the same period of 2020, incl. 2% increase of sales for the domestic market and 31% decrease in export sales.